To date, only 37 of 194 countries that signed up to implement the WHO Global action plan on dementia have created and funded national dementia plans. Our new campaign aims to galvanise and encourage more governments to develop national dementia plans following their 2017 commitment.
The study by Institute for Health Metrics and Evaluation (IHME) published in The Lancet predicts 153 million people will be living with Alzheimer’s disease by 2050.
Alzheimer’s Disease International (ADI) and ITN Productions have co-produced a new documentary ‘Hope in the Age of Dementia'.
The following piece is from our third 'From Plan to Impact' report and written by ADI's Communications and Policy Manager, Annie Bliss, the main author of the report. In this piece, she writes about the impact of the COVID-19 pandemic on diagnostic, treatment, care and support services for people living with dementia.
A new report by ADI calls on world governments to ensure that dementia remains a priority during and after the COVID-19 pandemic.
Catherine Hall, Chief Executive of Alzheimers New Zealand, writes about how Alzheimers New Zealand has responded and adapted to COVID-19, both in the first weeks of lockdown and today.
Alzheimer’s Disease International (ADI) and partner Dementia Alliance International (DAI) join other civil society organisations in a statement to the World Health Organization (WHO).
In advance of the 73rd World Health Assembly, ADI is sharing a statement submitted to the World Health Organization (WHO) and Member States.
A new study in the Lancet Neurology has shown that blood phosphorylated tau 181 may be a promising biomarker for Alzheimer’s disease.
ADI welcomes three new Alzheimer associations, as well as new members to the ADI board.